Hamilton James C's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Apr 3, 2024
- Accession no.
- 0001628280-24-014735
- Filed
- Apr 3, 2024
- Trade date
- Apr 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $168.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hamilton James CCIK 0001830755 | Officer (Chief Discovery/Trans Medicine) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Common Stock | SSaleDisposed | −6,000 | $28.03 | −$168,180 | 204,851 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.